Brief: Onxeo Applies For Admission To Trading On Nasdaq First North Growth Market Denmark
Nov 27 (Reuters) - ONXEO SA C4X.PA :
* HAS APPLIED FOR ADMISSION TO TRADING ON NASDAQ FIRST NORTH
GROWTH MARKET DENMARK AND DELISTING FROM NASDAQ MAIN MARKET
COPENHAGEN
* FIRST TRADING DAY ON NASDAQ FIRST NORTH GROWTH MARKET
DENMARK
WILL BE 14 DECEMBER 2020
* WILL CONTINUE TO TRADE UNDER ISIN CODE FR0010095596 AND
TICKER
SYMBOL ONXEO ON NASDAQ FIRST NORTH GROWTH MARKET
Source text for Eikon: ID:nBw5Wf403a
Further company coverage: C4X.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln